l-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: A multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure
- 1 August 2001
- journal article
- clinical trial
- Published by Springer Nature in Clinical Autonomic Research
- Vol. 11 (4) , 235-242
- https://doi.org/10.1007/bf02298955
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Rapid increase of fall-related severe head injuries with age among older people: a population-based study.Journal of the American Geriatrics Society, 1999
- The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserineNeurology, 1999
- Postural Hypotension: Causes, Clinical Features, Investigation, and ManagementAnnual Review of Medicine, 1999
- Efficacy of Midodrine vs Placebo in Neurogenic Orthostatic HypotensionJAMA, 1997
- Autonomic Disorders and Their RecognitionNew England Journal of Medicine, 1997
- Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor l-threo-3,4-dihydroxyphenylserineJournal of the Autonomic Nervous System, 1997
- Could Treatment with DOPS Do for Autonomic Failure What DOPA Did for Parkinson's Disease?Neurology, 1996
- Intravenous morphine causes hypertension, hyperglycaemia and increases sympatho-adrenal outflow in conscious rabbitsClinical Science, 1988
- Effect of L‐threo‐3,4‐dihydroxy‐phenylserine on muscle sympathetic nerve activities in Shy‐Drager syndromeNeurology, 1988
- Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathyEuropean Journal of Clinical Pharmacology, 1982